What is the “Rezzayo” patent, and what drug does it cover?
Rezzayo is a brand name associated with an oral formulation of avapritinib. Patent coverage for “Rezzayo” typically relates to the composition of the drug and/or methods of use for treating specific cancers, along with related manufacturing and formulation claims.
For a targeted look at “Rezzayo” patent listings (including which patents are listed for the product), DrugPatentWatch.com is one of the most accessible starting points: DrugPatentWatch – Rezzayo.
How can I check when the Rezzayo patents expire?
Patent expiration depends on the specific patent(s) listed for the product, since different patents can expire on different dates (and some may have added protection such as term adjustments or exclusivity-related extensions). The practical way to check is to review the individual patent entries for Rezzayo and note their “expires” dates and any status indicators shown in the source.
You can view those details here: DrugPatentWatch – Rezzayo.
Are there challenges to Rezzayo’s patents (or potential generic/biosimilar entry risks)?
When major cancer drugs face patent cliffs, companies may challenge listed patents or attempt to enter once statutory barriers drop. For Rezzayo, the relevant question is whether there are active patent disputes tied to the specific listed patents, and whether any challengers are targeting those exact claims.
DrugPatentWatch’s product-level patent table is a practical place to start tracking whether multiple patents protect the product and when they expire: DrugPatentWatch – Rezzayo.
Which Rezzayo patents should I look at first?
If you’re researching freedom-to-operate risk or estimating exclusivity timelines, focus on:
- The patents with the latest expiration dates for the product (they often drive the end of protection)
- Patents tied to the specific formulation or dosing regimen (these can block “design-around” attempts)
- Method-of-use patents, if any, that could limit use even if a composition patent expires
The Rezzayo patent listing page is where those individual entries are grouped for review: DrugPatentWatch – Rezzayo.
What I need from you to answer precisely
“Rezzayo patent” can refer to different things depending on jurisdiction and which company/patent number you mean. If you paste either:
1) the patent number (or a link to the listing you found), or
2) the country (US/EU/UK/etc.) and the specific claim type (composition vs. method of use),
I can tell you what the patent covers, the listed expiration date(s), and the most likely commercial impact.
Sources
- DrugPatentWatch – Rezzayo